For research access and to learn how you can work with Alembic Global Advisors please email Stephen Matthews, stephen.matthews@alembicglobal.com.
Key Points Q2’25 EPS and EBITDA miss and Q3’25 guidance below consensus. Dividend cut by 50% Near-term commentary cautious, driven by tepid demand and industry oversupply We rate Dow Inc. shares Neutral with...
Key Points We’re updating our forecast for RTX post yesterday’s 2Q earnings release, raising our topline outlook while lowering our adjusted EPS forecast, as we include the impact of the U.S....
Key Points Benign demand and diminishing innovation have resulted in years of chemical equity underperformance Consolidation, integration, innovation, rationalization, relocation, and restructuring key to future success of the industry We currently see the...
Key Points We believe feedstock costs lagged product prices in Q2'25, we anticipate a weak Q2’25 earnings season We are meaningfully above Q2’25 and 2025 consensus for CE and MEOH We are meaningfully...
Key Points We’re updating our forecast for BA after yesterday’s release of 2Q orders and deliveries information, and we're raising our target price by USD42 to USD265. We’re also reiterating our...